ROG

CHF237.10

▲+0.98%

wb_incandescent Backtest

Stock

Roche Holding AG

Official Company Name: Roche Holding AG

Stock Symbol: ROG

Stock Market: Swiss Exchange - SIX

Currency: Swiss franc - CHF

business Roche Company Profile

ROG Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▼-16.34%

file_download

Daily closing prices, with moving averages and volumes - Swiss franc (CHF)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Roche is a global healthcare company involved in prescription pharmaceuticals and diagnostics. It offers pharmaceutical products for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, and ophthalmology. It also provides in vitro diagnostics solutions for several indications, supplies diagnostic instruments, reagents, consumables, and test kits for research, and collaborates with other companies for drug development.

business Roche Company Profile

ROG Stock Data

Open CHF235.10
High CHF237.80
Low CHF234.00
Close CHF237.10
Volume 1,769,678
Previous Close CHF234.80
1-Day Change 2.30
1-Year Change -46.30
Average Daily Volume 1,250,130
52-Week High CHF292.80
52-Week Low CHF214.10
warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.